Antiplatelet therapy in coronary artery disease after surgical revascularization
https://doi.org/10.18705/1607-419X-2009-15-3-256-261
Abstract
The article summarizes the data on antiplatelet therapy in patients with coronary artery disease (CAD) undergoing coronary artery bypass graft surgery. The results of both randomized and open efficiency and safety trials of acetylsalicylic acid (ASA) and clopidogrel in the perioperative period are discussed as well as our own study results on association of ASA postoperative therapy with CAD recurrence after surgical revascularization are presented.
About the Authors
A. Panov
Federal Heart, Blood and Endocrinology Centre
Russian Federation
Russian Federation
M. L. Gordeev
Federal Heart, Blood and Endocrinology Centre
Russian Federation
Russian Federation
V. Y. Kozulin
Federal Heart, Blood and Endocrinology Centre
Russian Federation
Russian Federation
K. V. Korzhenevskaya
Federal Heart, Blood and Endocrinology Centre
Russian Federation
Russian Federation
N. A. Tyan
Federal Heart, Blood and Endocrinology Centre
Russian Federation
Russian Federation
References
1. Motwani J.G., Topol E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition and prevention // Circulation. - 1998. - Vol. 97. - P. 916 -931.
2.
3. Nezic D.G., Knezevic A.M., Milojevic P.S. et al. The fate of the radial artery conduit in coronary artery bypass grafting surgery // Eur. J. Cardiothorac. Surg. - 2006. - Vol. 30. - P. 341-346.
4.
5. Cannon C.P., Mehta S.R., Aranki S.F. Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery // Ann. Thorac. Surg. - 2005. - Vol. 80. - P. 768-779.
6.
7. Dacey L.J., Munoz J.J., Johnson E.R. et al. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients // Ann. Thorac. Surg. - 2000. - Vol. 70. -P. 1986-1990.
8.
9. Klein M., Keith P.R., Dauben H.P. et al. Aprotinin counterbalances an increased risk of peri-operative hemorrhage in CABG patients pre-treated with aspirin // Eur. J. Cardiothorac. Surg. - 1998. - Vol. 14. - P. 360-366.
10.
11. Bybee K.A., Powell B.D., Valeti U. et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting // Circulation. - 2005. - Vol. 112. - P. I286-I292.
12.
13. Mangano D.T. Aspirin and mortality from coronary bypass surgery // N. Engl. J. Med. - 2002. - Vol. 347. - P. 1309-1317.
14.
15. Michelson E.L., Morganroth J., Torosian M. et al. Relation of preoperative use of aspirin to increased mediastinal blood loss after coronary artery bypass graft surgery // J. Thorac. Cardiovasc. Surg. - 1978. - Vol. 76. - P. 694- 697.
16.
17. Taggart D.P., Siddiqui A., Wheatley D.J. Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements // Ann. Thorac. Surg. - 1990. - Vol. 50. - P. 424-428.
18.
19. Ferraris V.A., Ferraris S.P., Joseph O. et al. Aspirin and postoperative bleeding after coronary artery bypass grafting // Ann. Surg. - 2002. - Vol. 235. - P. 820-827.
20.
21. Bashein G., Nessly M.L., Rice A.L. et al. Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery // Arch. Intern. Med. - 1991. - Vol. 151. - P. 89-93.
22.
23. Srinivasan A.K., Grayson A.D., Pullan D.M. et al. Effect of preoperative aspirin use in off-pump coronary artery bypass operations // Ann. Thorac. Surg. - 2003. - Vol. 76. - P. 41-45.
24.
25. Alghamdi A.A., Moussa F., Fremes S.E. Does the use of preoperative aspirin increase the risk of bleeding in patients undergoing coronary artery bypass grafting surgery? Systematic review and meta-analysis // J. Card. Surg. - 2007. - Vol. 22. - P. 247-256.
26.
27. Sun J.C., Whitlock R., Cheng J. et al. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies // Eur. Heart J. - 2008. - Vol. 29. - P. 1057-1071.
28.
29. Ferraris V.A., Ferraris S.P., Moliterno D.J. et al. The society of thoracic surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary) // Ann. Thorac. Surg. - 2005. - Vol. 79. - P. 1454-1461.
30.
31. Goldman S., Copeland J., Moritz T. et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study // Circulation. - 1989. - Vol. 80. - P. 1190-1197.
32.
33. Chesebro J.H., Fuster V., Elveback L.R. et al. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations // N. Engl. J. Med. - 1984. - Vol. 310. - P. 209-214.
34.
35. Goldman S., Copeland J., Moritz T. et al. Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA cooperative study // Circulation. - 1994. - Vol. 89. - P. 1138-1143.
36.
37. Brooks N., Wright J., Sturridge M. et al. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion // Br. Heart J. - 1985. - Vol. 53. - P. 201-207.
38.
39. Gavaghan T.P., Gebski V., Baron D.W. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study // Circulation. - 1991. - Vol. 83. - P. 1526-1533.
40.
41. McEnany M.T., Salzman E.W., Mundth E.D. et al. The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts // J. Thorac. Cardiovasc. Surg. - 1982. - Vol. 83. - P. 81-89.
42.
43. Sharma G.V., Khuri S.F., Josa M. et al. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency // Circulation. - 1983. - Vol. 68. - P. II218 -II221.
44.
45. Brown B.G., Cukingnan R.A., DeRouen T. et al. Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery // Circulation. - 1985. - Vol. 72. - P. 138-146.
46.
47. Lim E., Ali Z., Ali A. et al. Indirect comparison meta-analysis of aspirin therapy after coronary surgery // Br. Med. J. - 2003. - Vol. 327. - P. 1309-1311.
48.
49. Fremes S.E., Levinton C., Naylor C.D. et al. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis // Eur. J. Cardiothorac. Surg. - 1993. - Vol. 7. - P. 169-180.
50.
51. Stein P.D., Schunemann H.J., Dalen J.E. et al. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy // Chest. - 2004. - Vol. 126 (3 Suppl.). - P. 600S-608S.
52.
53. Braunwald E., Antman E.M., Beasley J.W. et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) // Circulation. - 2002. - Vol. 106. -P. 1893-1900.
54.
55. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee // Lancet. - 1996. - Vol. 348. - P. 1329-1339.
56.
57. Yusuf S., Zhao F., Mehta S.R. et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation // N. Engl. J. Med. - 2001. - Vol. 345. - P. 494-502.
58.
59. Steinhubl S.R., Berger P.B., Mann J.T. III et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial // JAMA. - 2002. - Vol. 288. - P. 2411-2420.
60.
61. Saw J., Topol E.J., Steinhubl S.R. et al. Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention // Am. J. Cardiol. - 2004. - Vol. 94. - P. 623-625.
62.
63. Gurbuz A.T., Zia A.A., Vuran A.C. et al. Postoperative Clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study // Eur. J. Cardiothorac. Surg. - 2006. - Vol. 29, № 2. - P. 190-195.
64.
65. Kulik A., Chan V., Ruel M. Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy // Expert Opin. Drug Saf. - 2009. - Vol. 8, № 2. - P. 169-182.
66.
67. Kulik A., Le May M., Wells G.A. et al. The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423] // Curr. Control Trials Cardiovasc. Med. - 2005. - Vol. 6. - P. 15.
68.
69. Clopidogrel and Aspirin after Surgery for Coronary Artery Disease Study (NCT00776477). ClinicalTrials.gov Web site. URL: http://www.clinicaltrials.gov/ct2/show/NCT007764
70.
71. Dunning J., Versteegh M., Fabbri A. et al. on behalf of the EACTS Audit and Guidelines Committee Guideline on antiplatelet and anticoagulation management in cardiac surgery // Eur. J. Cardiothorac. Surg. - 2008. - Vol. 34. - P. 73-92.
72.
Review
For citations:
Panov A., Gordeev M.L., Kozulin V.Y., Korzhenevskaya K.V., Tyan N.A. Antiplatelet therapy in coronary artery disease after surgical revascularization. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2009;15(3):256-261. (In Russ.) https://doi.org/10.18705/1607-419X-2009-15-3-256-261
Views:
960
Email this article 